References

Ackermann, S., M.W. Beckmann, F. Thiel and T. Bogenrieder, 2007. Topotecan in cervical cancer. Int. J. Gynecol. Cancer, 17: 1215-1223.

Adesina, O.A., I.A. Babarinsa, O.A. Fawole, A. Oladokun, A.R. Adeniji and I.F. Adewole, 2003. Cervical cytology service in Nigeria: Providers` perspective. J. Obstet. Gynaecol., 23: 416-418.

Alberts, D.S., D. Garcia and N. Mason-Liddil, 1998. Cisplatin in advanced cancer of the cervix: An update. Seminars Oncol., 18: 11-13.

Ayinde, O.A. and A.O. Omigbodun, 2003. Knowledge, attitude and practices related to prevention of cancer of the cervix among female health workers in Ibadan. J. Obstet. Gynaecol., 23: 59-62.

Barrington, J.W., S. Brough and T.P. Stephenson, 1997. Reconstructive surgery in advanced cervical cancer. J. Obstet. Gynaecol., 17: 103-103.

Buckley, C.H. and H. Fox, 1993. Pathology of Clinical Invasive Carcinoma of Cervix. In: Gynecology Oncology, Coppleson, M. (Ed.). Vol. 1, Churchill Livingstone, Australia, pp: 649-662.

Busuttil, R., M. Dalmas and A.C. Vincent, 2006. Effectiveness of opportunistic screening for cancer of the cervix uteri. Malta Med. J., 18: 15-20.

Chen, C.H., K.C. Chao and P.H. Wang, 2007. Advanced cervical squamous cell carcinoma with skin metastasis. Taiwan J. Obstet. Gynecol., 46: 264-266.

Chiara, S., R. Consoli, A. Falcone, M. Bruzzone, G. Foglia, N. Ragni and P.F. Conte, 1988. Cisplatin and 5-flourouracil in advanced and recurrent cervical cancer. Tumori, 74: 471-474.

Connolly, T.P. and A.C. Evans, 2005. Atypical Papanicolaou smear in Pregnancy. Clin. Med. Res., 3: 13-18.

Craus, J., Y. Muscat-Baron and M. Brincat, 2005. Obstetrics and gynaecology. Malta Med. J., 17: 41-45.

Cubie, H.A., 2007. Papillomaviruses and Polyomaviruses. In: Medical Microbiology, Greenwood, D., R. Slack, J. Peutherer and M. Barer (Eds.). Vol. 45, Churchill Livingsone Elsevier, USA., pp: 446-456.

Disaia, P.J. and W.T. Creasman, 2002. Clinical Gynaecologic Oncology. 6th Edn., Mosby Inc., California, USA.

Geier, C.S., M. Wilson and W. Creasman, 2001. Clinical evaluation of atypical glandular cells of undetermined significance. Am. J. Obstet. Gynecol., 184: 64-69.

Ghaemmaghami, F., N. Behtash, F. Yarandi, A. Moosavi, M. Modares, G. Toogeh and N. Khanafshar, 2003. First-line chemotherapy with 5-FU and platinum for advanced and recurrent cancer of the cervix: A phase II study. J. Obstet. Gynaecol., 23: 422-425.

Gray, H.J., 2008. Primary management of early stage cervical cancer (IA1-IB) and appropriate selection of adjuvant therapy. J. Natl. Compr. Cancer Network, 6: 47-52.

IARC (Working Group on the Evaluation of Cancer-Preventive Strategies), 2005. Handbooks of Cancer Prevention, Cervix Cancer Screening. Vol. 10, IARC Press, Lyon, France.

Kish, J.A., J.F. Ensley, J. Jacobs, A. Weaver, G. Cummings and M. Al-Sarraf, 1985. A randomized trial of cisplatin + 5-FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck. Cancer, 56: 2740-2744.

Landro, M.E., D. Dalbert, M.A. Picconi, N. C�neo and J. Gonzalez et al., 2008. Human papillomavirus and mutated H-ras oncogene in cervical carcinomas and pathological negative pelvic lymph nodes: A retrospective follow-up. J. Med. Virol., 80: 694-701.

Liman, A.K., E.J. Giampoli and T.A. Bonfiglio, 2005. Should women with atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion, receive reflex human papillomavirus-DNA testing?. Cancer, 105: 457-460.

Liu, D.W., Y.P. Tsao, J.T. Kung, Y.A. Ding, H.K. Sytwu, X. Xiao and S.L. Chen, 2000. Recombinant adeno-associated virus expressing human papillomavirus type 16 E7 peptide DNA fused with heat shock protein DNA as a potential vaccine for cervical cancer. J. Virol., 74: 2888-2894.
Direct Link  |  

Lowy, D.R. and J.T. Schiller, 2006. Prophylactic human papillomavirus vaccines. J. Clin. Invest., 116: 1167-1173.

Manos, M.M., W.K. Kinney, L.B. Hurley, M.E. Sherman and J. Shieh-Ngai et al., 1999. Identifying women with cervical neoplasia: Using human papillomavirus DNA testing for equivocal papanicolaou results. J. Am. Med. Assoc., 281: 1605-1610.

Mood, N.I., Z. Eftekhar, A. Haratian, L. Saeedi, P. Rahimi-Moghaddam and F. Yarandi, 2006. A cytohistologic study of atypical glandular cells detected in cervical smears during cervical screening tests in Iran. Int. J. Gynecol. Cancer, 16: 257-261.

Murta, E.F., C.S. da Silva, J.B. Vieira, K.M. Khabbaz and S.J. Adad, 2007. Cervical neoplasia after diagnosis and follow-up of women with atypical squamous cells of undetermined significance. Clin. Exp. Obstet. Gynecol., 34: 219-222.

Palefsky, J., 2002. What Your Doctor May Not Tell You About HPV and Abnormal Pap Smears. Warner Books, New York, USA.

Parkin, D.M., P. Pisani and J. Ferlay, 1993. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int. J. Cancer, 54: 594-606.
PubMed  |  Direct Link  |  

Pearcey, R., M. Brundage, P. Drouin and J. Jeffrey, D. Johnston et al., 2002. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J. Clin. Oncol., 20: 966-972.

Quint, W.G.V., S.R. Pagliusi, N. Lelie, E.M. de Villiers and C.M. Wheeler, 2006. Results of the first world health organization international collaborative study of detection of human papillomavirus. J. Clin. Microbiol., 44: 571-579.

Randall-Whitis, L.M. and B.J. Monk, 2007. Topotecan in the management of cervical cancer. Expert Opin. Pharmacother., 8: 227-236.

Rose, P.G., S. Ali, E. Watkins, J.T. Thigpen, G. Deppe, D.L. Clarke-Pearson and S. Insalaco, 2007. Long term follow up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: A gynecologic oncology group study. J. Clin. Oncol., 25: 2804-2810.

Scheiden, R., C. Wagener, U. Knolle, W. Dippel and C. Capesius, 2004. Atypical glandular cells in conventional cervical smears: Incidence and follow-up. BMC Cancer, 4: 37-37.

Tatti, S.A., 2003. Epidemiology of HPV. In: Colposcopy: Management Options, Prendiville, W., J. Ritter, S.A. Tatti and L.B. Twiggs (Eds.). Saunders, Ireland, pp: 1-5.

Wu, H.H., S.L. Allen, J.L. Kirkpatrick and T.M. Elsheikh, 2006. Reflex high-risk human papilloma virus DNA test is useful in the triage of women with atypical squamous cells cannot exclude high-grade squamous intraepithelial lesion. Diagn. Cytopathol., 34: 707-710.